CCM
BNTX icon

Coldstream Capital Management’s BioNTech BNTX Stock Holding History

Coldstream Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24
Closed -$2.19K – 1420
2025
Q1 		$2.19K Buy
+24
New +$2.69K ﹤0.01% 2978

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Coldstream Capital Management's BNTX Position: Q2 2025 in Review

Coldstream Capital Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 24 shares — an estimated $2.19K sold.

Coldstream Capital Management first reported a position in BNTX in Q1 2025 and held it in 1 quarter. The position peaked at $2.19K in Q1 2025. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Coldstream Capital Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 24 BioNTech shares in Q2 2025, an estimated $2.19K.
  • Coldstream Capital Management first reported a position in BioNTech in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's BioNTech position peaked at $2.19K in Q1 2025.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.